지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.2
- 수록면
- 264 - 272 (9page)
- DOI
- 10.1038/s12276-024-01157-7
이용수
초록· 키워드
오류제보하기
Osteoclasts are the principal cells that efficiently resorb bone. Numerous studies have attempted to reveal the molecular pathways leading to the differentiation and activation of osteoclasts to improve the treatment and prevention of osteoporosis and other bone-destructive diseases. While the cumulative knowledge of osteoclast regulatory molecules, such as receptor activator of nuclear factor-kB ligand (RANKL) and nuclear factor of activated T cells 1 (NFATc1), contributes to the understanding of the developmental progression of osteoclasts, little is known about how the discrete steps of osteoclastogenesis modify osteoclast status but not the absolute number of osteoclasts. The regulatory mechanisms involved in osteoclast maturation but not those involved in differentiation deserve special attention due to their potential use in establishing a more effective treatment strategy: targeting late-phase differentiation while preserving coupled bone formation. Recent studies have shed light on the molecules that govern late-phase osteoclast differentiation and maturation, as well as the metabolic changes needed to adapt to shifting metabolic demands. This review outlines the current understanding of the regulation of osteoclast differentiation, as well as osteoclast metabolic adaptation as a differentiation control mechanism. Additionally, this review introduces molecules that regulate the late-phase osteoclast differentiation and thus minimally impact coupled bone formation.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
SU-8 Inhibit Osteoclast Differentiation by downregulating NFATc1
한국생물공학회 학술대회
2017 .10
-
Adipose Tissue-Derived Mesenchymal Stem Cell Inhibits Osteoclast Differentiation through Tumor Necrosis Factor Stimulated Gene-6
조직공학과 재생의학
2024 .06
-
PyP-R13-6 Inhibits Osteoclast Differentiation In vitro and In vivo
한국생물공학회 학술대회
2017 .04
-
Remifentanil Negatively Regulates RANKL-Induced Osteoclast Differentiation and Bone Resorption by Inhibiting c-Fos/NFATc1 Expression
조직공학과 재생의학
2018 .01
-
Afatinib ameliorates osteoclast differentiation and function through downregulation of RANK signaling pathways
BMB Reports
2017 .01
-
Tusc2/Fus1 regulates osteoclast differentiation through NF-kB and NFATc1
BMB Reports
2017 .01
-
The IRF2BP2-KLF2 axis regulates osteoclast and osteoblast differentiation
BMB Reports
2019 .01
-
Selective regulation of osteoclast adhesion and spreading by PLCγ/PKCα-PKCδ/RhoA-Rac1 signaling
BMB Reports
2018 .01
-
Inhibitory effects of acid extracts from Gracilaria verrucosa on osteoclast differentiation in vitro
한국생물공학회 학술대회
2016 .10
-
2-O-digalloyl-1,3,4,6-tetra-O-galloyl--D-glucose isolated from Galla Rhois suppresses osteoclast differentiation and function by inhibiting NF-B signaling
BMB Reports
2019 .01
-
Inhibitory effects of deguelin on osteoclast differentiation in vitro
한국생물공학회 학술대회
2016 .04
-
RACK1 interaction with c-Src is essential for osteoclast function
Experimental and Molecular Medicine
2019 .01
-
Dehydrocostus lactone inhibits NFATc1 via regulation of IKK, JNK, and Nrf2, thereby attenuating osteoclastogenesis
BMB Reports
2020 .01
-
Flrt2 is involved in fine-tuning of osteoclast multinucleation
BMB Reports
2019 .01
-
IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
BMB Reports
2021 .09
-
Savinin Suppresses Osteoclast Formation via Down-regulating NFATc1
한국생물공학회 학술대회
2017 .04
-
Spi-C positively regulates RANKL-mediated osteoclast differentiation and function
Experimental and Molecular Medicine
2020 .01
-
Serum amyloid A inhibits RANKL-induced osteoclast formation
Experimental and Molecular Medicine
2015 .01
-
The estrogen-related receptor γ modulator, GSK5182, inhibits osteoclast differentiation and accelerates osteoclast apoptosis
BMB Reports
2021 .01
-
Pentamidine Inhibits Titanium Particle-Induced Osteolysis In Vivo and Receptor Activator of Nuclear Factor-κB Ligand-Mediated Osteoclast Differentiation In Vitro
조직공학과 재생의학
2019 .01
최근 본 자료
댓글(0)
0